Search research articles
Contact Us
Filters
Showing results (21-30 of 122) with videos related to
Page
of 13
Sort By:
Journal of Diabetes and Its Complications
|
September 4, 2019
Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Cardiovascular Diabetology
|
March 12, 2014
Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Current Atherosclerosis Reports
|
July 17, 2020
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?
Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib
Journal of Clinical & Translational Endocrinology
|
July 14, 2023
Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes
Fabian Lurquin, Sophie Gohy, Michel P Hermans, et al.
Journal of Diabetes and Its Complications
|
December 21, 2013
Parental brevity linked to cardiometabolic risk in diabetic descendants
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Acta Cardiologica
|
March 24, 2020
Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Lipids in Health and Disease
|
September 14, 2017
The mixed benefit of low lipoprotein(a) in type 2 diabetes
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
European Journal of Clinical Investigation
|
January 10, 2012
eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetes
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Journal of Clinical and Translational Hepatology
|
September 18, 2023
A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes Patients
Quentin Binet, Audrey Loumaye, Michel P Hermans, et al.
Acta Diabetologica
|
November 7, 2013
What are the characteristics of phenotypic type 2 diabetic patients with low-titer GAD65 antibodies?
Yovan P Mahadeb, Damien Gruson, Martin Buysschaert, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 122) with videos related to
Sort By:
Page
of 13
Journal of Diabetes and Its Complications
|
September 4, 2019
Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Cardiovascular Diabetology
|
March 12, 2014
Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Current Atherosclerosis Reports
|
July 17, 2020
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?
Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib
Journal of Clinical & Translational Endocrinology
|
July 14, 2023
Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes
Fabian Lurquin, Sophie Gohy, Michel P Hermans, et al.
Journal of Diabetes and Its Complications
|
December 21, 2013
Parental brevity linked to cardiometabolic risk in diabetic descendants
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Acta Cardiologica
|
March 24, 2020
Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Lipids in Health and Disease
|
September 14, 2017
The mixed benefit of low lipoprotein(a) in type 2 diabetes
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
European Journal of Clinical Investigation
|
January 10, 2012
eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetes
Michel P Hermans, Sylvie A Ahn, Michel F Rousseau
Journal of Clinical and Translational Hepatology
|
September 18, 2023
A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes Patients
Quentin Binet, Audrey Loumaye, Michel P Hermans, et al.
Acta Diabetologica
|
November 7, 2013
What are the characteristics of phenotypic type 2 diabetic patients with low-titer GAD65 antibodies?
Yovan P Mahadeb, Damien Gruson, Martin Buysschaert, et al.
Page
of 13